CagriSema would be the first combo GLP-1 if it’s approved, while orforglipron would be the first GLP-1 pill approved for ...
Eli Lilly might have a solution for patients trying to decide whether to stay on obesity treatments forever. A study showed ...
Novo Nordisk said on Thursday it had filed a marketing application with the U.S. Food and Drug Administration for CagriSema, ...
Eli Lilly (NYSE:LLY) is rapidly establishing itself as the leader in GLP-1 treatments for weight loss. Its Zepbound injection ...
Eli Lilly's oral pill helped maintain weight loss in patients switching from its GLP-1 injection, Zepbound, and rival Novo ...
The filing comes as Novo fights tooth-and-nail with rival Lilly to regain its footing at the top of the weight loss market.
Outlook Business on MSN
Social Media ‘Doctors’ are Driving Indians to Weight-Loss Drugs Like Mounjaro, Wegovy. It’s Illegal
Social media advertisements of weight-loss drugs such as Wegovy and Mounjaro is illegal as per the India law, lawyers tell ...
Even so, in an interview with The Economist, Mr Doustdar sounded confident that Novo can recover. His prescription is to push a new generation of obesity treatments while making sweeping changes to ...
Doctors and groups representing employers said they’re increasingly hearing about companies cutting weight loss drugs out of ...
Indian health-tech startup Healthify is in talks to partner with more weight-loss drugmakers to offer health, nutrition and ...
Pop Mart, the Chinese firm behind the mischievously grinning, nine-toothed Labubu dolls that shoppers have queued up to buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback